CEL-SCI CORPORATION
Healthcare · Biotechnology & Medical Research
CLARITY GRADE · crash risk, updated Tuesdays
week of Nov 16
FRACTURED
8 weeks at this grade
More of these stocks dropped 20%+ than rose 20%+.
| Fact | This stock | Similar stocks that dropped 20%+ |
|---|---|---|
| Price swings, last 60 days | wilder than 91% of stocks under $10B | 44 vs typical 23 of 100 |
| Distance below its 52-week high | 78% below | 37 vs typical 23 of 100 |
| Finances vs industry peers (return on equity, operating cash flow) | return on equity above 12% of peers, cash flow yield above 21% | 32 vs typical 23 of 100 |
| New shares issued over the last year | share count +155.6% |
| 34 vs typical 23 of 100 |
| Trading heat vs peers (shares traded / shares outstanding) | more than 27% of peers | 21 vs typical 23 of 100 |
Past stocks scored each week from January 2024 to June 2026, using only data available at the time, then checked 60 trading days later. A grade is about holding up, not about gains, and it is not a buy or sell signal. How the grades are tested